| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | President &CSO
1 company
Shacham Sharon is a Chief Scientific Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $8.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2017 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $10.39 | $103,903.00 | -1.4% | |
| Jan 12, 2015 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sell | 50,000 | $33.00 | $1,650,000.00 | -3.6% |